Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Net Margin (2016 - 2025)

Historic Net Margin for Harvard Bioscience (HBIO) over the last 16 years, with Q3 2025 value amounting to 5.99%.

  • Harvard Bioscience's Net Margin rose 158600.0% to 5.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.53%, marking a year-over-year decrease of 470100.0%. This contributed to the annual value of 13.18% for FY2024, which is 101400.0% down from last year.
  • Latest data reveals that Harvard Bioscience reported Net Margin of 5.99% as of Q3 2025, which was up 158600.0% from 11.17% recorded in Q2 2025.
  • Harvard Bioscience's 5-year Net Margin high stood at 8.34% for Q2 2022, and its period low was 230.98% during Q1 2025.
  • Moreover, its 5-year median value for Net Margin was 5.99% (2025), whereas its average is 18.56%.
  • Per our database at Business Quant, Harvard Bioscience's Net Margin soared by 259300bps in 2023 and then crashed by -2118300bps in 2025.
  • Over the past 5 years, Harvard Bioscience's Net Margin (Quarter) stood at 1.78% in 2021, then crashed by -526bps to 7.61% in 2022, then increased by 15bps to 6.46% in 2023, then soared by 103bps to 0.2% in 2024, then crashed by -3043bps to 5.99% in 2025.
  • Its last three reported values are 5.99% in Q3 2025, 11.17% for Q2 2025, and 230.98% during Q1 2025.